Usuki Jiro

ウスキジロウ | Usuki Jiro

Affiliation and department：
Job title： Director

Research field (1)： Respiratory medicine

Research keywords (2)：呼吸器内科学 , Respiratory medicine

Research theme for competitive and other funds (5)：

2016 - 2020 Exploratory study on endothelial microparticles (EMPs) as possible markers of interstitial lung diseases.
2014 - 2017 Study of topical antibody production in sinus mucosa of refractory rhinosinusitis cases
2004 - 2005 Control of pulmonary fibrosis by the intracellular transfection of Smad protein
間質性肺炎に関する研究
Study on Interstitial Pneumonia

Papers (30)：

Minoru Inomata, Koichiro Kamio, Arata Azuma, Kuniko Matsuda, Jiro Usuki, Akemi Morinaga, Toru Tanaka, Takeru Kashiwada, Kenichiro Atsumi, Hiroki Hayashi, et al. Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis. Experimental cell research. 2021. 398. 2. 112416-112416
Naoyuki Kuse, Koichiro Kamio, Arata Azuma, Kuniko Matsuda, Minoru Inomata, Jiro Usuki, Akemi Morinaga, Toru Tanaka, Takeru Kashiwada, Kenichiro Atsumi, et al. Exosome-derived microRNA-22 ameliorates pulmonary fibrosis by regulating fibroblast-to-myofibroblast differentiation both in vitro and in vivo. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2019
Kamio Koichiro, Azuma Arata, Matsuda Kuniko, Usuki Jiro, Inomata Minoru, Morinaga Akemi, Kashiwada Takeru, Nishijima Nobuhiko, Itakura Shioto, Kokuho Nariaki, et al. Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation. Respiratory research. 2018. 19. 1. 71-71
Kamio Koichiro, Azuma Arata, Usuki Jiro, Matsuda Kuniko, Inomata Minoru, Nishijima Nobuhiko, Itakura Shioto, Hayashi Hiroki, Kashiwada Takeru, Kokuho Nariaki, et al. XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts. Pulmonary pharmacology & therapeutics. 2017. 44. 61-69
Koichiro Kamio, Arata Azuma, Jiro Usuki, Kuniko Matsuda, Minoru Inomata, Nobuhiko Nishijima, Shioto Itakura, Hiroki Hayashi, Takeru Kashiwada, Nariaki Kokuho, et al. XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts. PULMONARY PHARMACOLOGY & THERAPEUTICS. 2017. 44. 61-69

ｍore...

MISC (128)：

山口朋禎, 坂本徹, 矢嶋知佳, 臼杵二郎, 清家正博, 弦間昭彦. COVID-19診療における地域連携の重要性. 第61回日本呼吸器学会学術集会. 2021. 10. 増刊. 143-143
神尾孝一郎, 吾妻安良太, 松田久仁子, 猪俣稔, 久世眞之, 臼杵二郎, 田中徹, 柏田建, 佐藤純平, 西島伸彦, et al. 自家骨髄細胞による肺線維症モデルマウスの病態改善効果に関する研究. 日本呼吸器学会誌. 2021. 10. 増刊. 179-179
神尾孝一郎, 吾妻安良太, 松田久仁子, 猪俣稔, 久世眞之, 臼杵二郎, 田中徹, 柏田建, 佐藤純平, 西島伸彦, et al. 自家骨髄細胞による肺線維症モデルマウスの病態改善効果に関する研究. 日本呼吸器学会誌. 2021. 10. 増刊. 179-179
神尾孝一郎, 吾妻安良太, 臼杵二郎, 松田久仁子, 猪俣稔, 西島伸彦, 國保成暁, 板倉潮人, 林宏紀, 山口朋禎, et al. HDAC inhibitorによるXPLNを介するmTORC2-SPARC経路の制御. 分子呼吸器病. 2018. 22. 1. 111-115
神尾孝一郎, 吾妻安良太, 臼杵二郎, 松田久仁子, 猪俣稔, 西島伸彦, 國保成暁, 板倉潮人, 林宏紀, 山口朋禎, et al. HDAC inhibitorによるXPLNを介するmTORC2-SPARC経路の制御. 分子呼吸器病. 2018. 22. 1. 111-115

ｍore...

Books (1)：

LAM and Other Diseases Characterized by Smooth Muscle Proliferation.
Marcel Dekker 1999

Professional career (1)：

(BLANK)

Work history (2)：

Nippon Medical School
Nippon Medical School Faculty of Medicine, Department of Medicine, Department of Respiratory Medicine Lecturer

Association Membership(s) (5)：

日本呼吸ケア・リハビリテーション学会 , THE JAPAN SOCIETY FOR RESPIRATORY ENDOSCOPY , 日本肺癌学会 , 日本内科学会 , 日本呼吸器学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page